Moneycontrol PRO
HomeNewsBusinessStocksBuy, sell, hold: 9 stocks you can watch out today

Buy, sell, hold: 9 stocks you can watch out today

Morgan Stanley has overweight rating on Bharat Financial with target at Rs 1125 per share. It says share price will rise relative to the industry over the next 30 days. Collection efficiency has been progressively improving.

November 30, 2016 / 16:27 IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Moneycontrol Bureau Here are brokerage views on 9 stocks for your portfolioUnited Spirits Morgan Stanley says improved capital efficiencies and debt reduction drives overweight rating. It says there are  initial signs of an improving industry construct with price hikes and  policy changes.

LIC HousingMorgan Stanley stays overweight with valuation of 2.2x FY18 BV attractive as return ratios resilient even on stressed earnings.

Tech MahindraMorgan Stanley is overweight with target at Rs 545 per share.

Bharat FinancialMorgan Stanley has overweight rating with target at Rs 1125 per share. It says share price will rise relative to the industry over the next 30 days. Collection efficiency has been progressively improving. Power GridCredit Suisse maintains outperform with target unchanged at Rs 225 per share as ordering in FY17-YTD has been strong at Rs 19000 crore. It estimates 14.5 percent CAGR growth over FY17-20.

ArvindCredit Suisse maintains outperform with target increased to Rs 430 from Rs 380 per share.  It has cut growth and  margin estimates for second half  of FY17 and FY18. It says high brand growth, improving financials make its  positive.

Bharat Financial Credit Suisse has upgraded stock to neutral from underweight but cuts target Rs 700 from Rs 710 per share. It has cut EPS estimates by 17 percent for FY17 and 10-11 percent for FY18/FY19. It says  recent correction now implies limited downside.

Idea CLSA retains sell call on the stock with target price at Rs 68 per share if it sells its tower biz, it could  reduce debt by 15 percent  to over 3times EBITDA. It says net interest savings due to tower business sale would boost profit by over 4-10 percent.

Torrent PharmaCLSA upgrade it to buy from outperform with target price unchanged at Rs 1730 per share as India formulations sales continue to gain momentum with 21 percent CAGR from FY13-16.

first published: Nov 30, 2016 10:07 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347